A pair of proteins that promote blood vessel formation are associated with the development of severe malaria, and they may be a target for future therapeutics, according to recent research.
Internationally renowned Swiss neuro-oncologist Roger Stupp, MD, will join Northwestern Medicine as a professor of Neurological Surgery.
Ronald Ackermann, MD, MPH, has been named senior associate dean for public health and director of the Institute for Public Health and Medicine (IPHAM), succeeding IPHAM’s inaugural leader, Rowland Chang, MD, MPH.
Northwestern University has been awarded a grant from the National Institutes of Health to help scientists across the country study how environmental factors influence health outcomes for children.
Northwestern Medicine scientists continue to demonstrate that a protein called Hrd1 may be an important target for treating autoimmune diseases.
For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.
Northwestern Medicine scientists have received a $7.5 million grant to study how genetic information from African American patients can predict their responses to medications.
Northwestern hosted the inaugural State of LGBT Health Symposium, bringing together scientists, policymakers and community members to discuss how federal resources are being mobilized to improve the health of lesbian, gay, bisexual, transgender, queer and gender-nonconforming people.
An expert panel led by Northwestern Medicine investigator Judith Paice, PhD, RN, developed recommendations to help clinicians manage the chronic pain of cancer survivors.
Northwestern Medicine scientists have identified a new potential target for treating autoimmune diseases in recent research published in Nature Communications.